Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
about
Pharmacogenetics of beta-blockersA case for pharmacogenomics in management of cardiac arrhythmias.Hemodynamic effects of renin-angiotensin-aldosterone inhibitor and β-blocker combination therapy vs. β-blocker monotherapy for portal hypertension in cirrhosis: A meta-analysisFibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.
P2860
Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Transforming growth factor bet ...... ion versus Atenolol (SILVHIA).
@en
Transforming growth factor bet ...... Investigation versus Atenolol
@nl
type
label
Transforming growth factor bet ...... ion versus Atenolol (SILVHIA).
@en
Transforming growth factor bet ...... Investigation versus Atenolol
@nl
prefLabel
Transforming growth factor bet ...... ion versus Atenolol (SILVHIA).
@en
Transforming growth factor bet ...... Investigation versus Atenolol
@nl
P2093
P2860
P50
P356
P1433
P1476
Transforming growth factor bet ...... tion versus Atenolol (SILVHIA)
@en
P2093
Ann-Christine Syvänen
Fredrik Nyström
Håkan Melhus
Julia Karlsson
K Peter Ohman
Karin Malmqvist
Katarina Billberger
Lisa Kurland
Ulrika Liljedahl
P2860
P304
P356
10.1002/CLC.4960270315
P577
2004-03-01T00:00:00Z